We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt.
- Authors
Frank, C; Mohamed, M K; Strickland, G T; Lavanchy, D; Arthur, R R; Magder, L S; El Khoby, T; Abdel-Wahab, Y; Aly Ohn, E S; Anwar, W; Sallam, I
- Abstract
The population of Egypt has a heavy burden of liver disease, mostly due to chronic infection with hepatitis C virus (HCV). Overall prevalence of antibody to HCV in the general population is around 15-20%. The risk factor for HCV transmission that specifically sets Egypt apart from other countries is a personal history of parenteral antischistosomal therapy (PAT). A review of the Egyptian PAT mass-treatment campaigns, discontinued only in the 1980s, show a very high potential for transmission of blood-borne pathogens. We examine the relative importance of PAT in the spread of HCV in Egypt.
- Publication
Lancet (London, England), 2000, Vol 355, Issue 9207, p887
- ISSN
0140-6736
- Publication type
Journal Article
- DOI
10.1016/s0140-6736(99)06527-7